Lack of beta-arrestin signaling in the absence of active G proteins
Manuel Grundmann(Bayer (Germany)), Evi Kostenis(University of Bonn), Katharina Simon(University of Bonn), Ines Müller(Mount Sinai Hospital), Ulrike Rick(University of Bonn), Junken Aoki(The University of Tokyo), Tobias Benkel(University of Bonn), Toni Kühl(University of Bonn), Nelly Rüttiger(Jena University Hospital), Diana Imhof(University of Bonn), Gabriele M. König(University of Bonn), Davide Malfacini(University of Bonn), Asuka Inoue(Tohoku University), Nina Schmitt(University of Bonn), Philip Preis(University of Bonn), Nicole Merten(Telstra (Australia)), Raphael Reher(Philipps University of Marburg), Kouki Kawakami(The University of Tokyo), Jesús Gomeza(University of Bonn), Ayumi Inoue(Tohoku University), Nicole Ziegler(University of Würzburg), Carsten Hoffmann(Schiller International University), Satoru Ishida(Tohoku University), Jürgen Wess(National Institute of Diabetes and Digestive and Kidney Diseases)
Cited by 382
Related Papers
Artificial intelligence for natural product drug discovery
|Nature Reviews Drug Discovery|2023|380
The experimental power of FR900359 to study Gq-regulated biological processes
|Nature Communications|2015|371
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340